
L&S Venture Capital
Description
L&S Venture Capital is a prominent venture capital firm based in Seoul, South Korea, actively contributing to the nation's burgeoning startup ecosystem. Established to foster innovation, the firm primarily focuses on early to growth-stage companies, demonstrating a versatile investment strategy across various high-potential sectors. Their portfolio reflects a strong inclination towards deep technology, including biotech, healthcare, artificial intelligence (AI), big data, smart factory solutions, and advanced manufacturing.
The firm's investment thesis centers on identifying companies with strong technological foundations and significant market disruption potential. L&S Venture Capital is known for its hands-on approach, often providing strategic guidance and leveraging its extensive network to support portfolio companies through their growth phases. While they participate in diverse funding rounds, their typical engagement involves supporting promising startups from their initial stages through follow-on investments as they scale.
L&S Venture Capital manages several specialized funds, underscoring its targeted investment approach. Notably, the firm oversees a significant fund of approximately 100 billion Korean Won (around 75 million USD) dedicated to investments in smart factories and deep technology. Additionally, they manage a separate fund of roughly 30 billion Korean Won (approximately 22 million USD) specifically earmarked for the bio and healthcare sectors. These dedicated funds highlight their commitment to fostering innovation in critical industries.
Through its strategic investments and active participation in the startup community, L&S Venture Capital plays a crucial role in nurturing South Korea's next generation of technology leaders. Their consistent support for innovative ventures, particularly in areas like biotechnology and AI, positions them as a key player in driving technological advancement and economic growth within the region.
Investor Profile
L&S Venture Capital has backed more than 20 startups, with 7 new investments in the last 12 months alone. The firm has led 2 rounds, about 10% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Seed, Series B rounds (top funding stages).
- Majority of deals are located in South Korea, Israel, United States.
- Strong thematic focus on Manufacturing, Artificial Intelligence (AI), Medical.
- Led 2 rounds in the past year.
- Typical check size: $500K – $5M.
Stage Focus
- Series A (35%)
- Seed (20%)
- Series B (20%)
- Series Unknown (15%)
- Series C (10%)
Country Focus
- South Korea (85%)
- Israel (5%)
- United States (5%)
Industry Focus
- Manufacturing
- Artificial Intelligence (Ai)
- Medical
- Hardware
- Saas
- Software
- Biotechnology
- Medical Device
- 3d Printing
- Graphic Design
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.